In Wipro, TCS, LTIMindtree and Infosys, FII stakes are 2-3 percentage points below the peak holding during rate hike cycle. For Tech Mahindra, the difference is as wide as 9 percentage points. With rate cycle turning, the view is big deal wins will soon resume from large clients
After patient nurturing over two decades, Reliance Life Sciences is investing in a new plant and looking to enter new segments. The biotechnology player could well be the next big thing from the Reliance stable
The pharma and healthcare sector presents a study in contrasts in terms of performance, both financially and in the BT500 ranking - Issue Date: Dec 11, 2022